We thus conclude that a strong CD8+ T cell-mediated ex vivo viral inhibition activity as well as a protective CD8+ T cell response targeting conserved viral epitopes contributes to the early control of HIV infection. The gene discussed is CD8A; the disease is HIV infectious disease.